2023
Release time：2023-04-18 10:32
KX-826 Phase III Clinical Trial for Treatment of Male AGA in China Completed
KX-826 Phase III Long-term Safety Clinical Trial in China Completed Patient Enrollment
GT1708 Obtained Conditional Approval to Conduct Phase II Clinical Trial in China by NMPA for IPF
KX-826 Phase II Clinical Trial for Treatment of Male AGA in the U.S. Completed
GT1708 Phase I Clinical Trial for Treatment of Hematologic Malignancies in China Completed
Enrolment completed in Chinese phase III clinical trial of Fruetane for male pattern baldness
GT20029 U.S. Phase I Clinical Trial Completed
recommend News
2025-06-25
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Powered by 300.cn